Japan Tobacco (2914) Q3 2025 earnings summary

Executive summary

• Nine-month consolidated results showed significant growth in revenue and profit, driven by strong tobacco business performance, the Vector Group acquisition, and favorable FX.

• The Pharmaceutical Business was divested and is now treated as a discontinued operation, with results presented separately.

• Upward revisions across all full-year indicators, with record-high figures for revenue, profit, and free cash flow.

• Annual dividend guidance was raised to JPY 234, reflecting robust performance and shareholder return policy.

• Ploom AURA ecosystem launch strengthened presence in the heated tobacco segment, accelerating share gains.

Financial highlights

• Nine-month core revenue reached JPY 2,580.3B (+15.3% YoY at constant FX); reported revenue JPY 2,634.0B (+13.2% YoY).

• Adjusted operating profit at constant FX was JPY 849.0B (+27.2% YoY); reported AOP JPY 814.7B (+22.1% YoY).

• Operating profit rose 20.8% YoY to JPY 762.9B; profit from continuing operations up 16.6% YoY to JPY 511.4B.

• Free cash flow forecast revised upward by JPY 44B, reflecting higher AOP.

• Basic earnings per share for the period were JPY 288.24, up from JPY 249.18 in the prior year.

Outlook and guidance

• Full-year 2025 revenue forecast revised up to JPY 3,456.0B (+13.2% YoY); AOP forecast at JPY 923.0B (+24.3% YoY).

• Operating profit forecast raised to JPY 845.0B; profit from continuing operations to JPY 555.0B.

• Dividend forecast for 2025 revised upward to JPY 234 per share, with a payout ratio of 74.9%.

• Tobacco business volume forecast revised to +2.0% YoY, up from previous -1.0% estimate.

• Mid to high single-digit growth targeted for next fiscal year, with no concern for a reactionary decline.